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Abstract
Background: The embryonic stem cell (ESC) factor, SALL4, plays an essential role in both development and leukemogenesis.
It is a unique gene that is involved in self-renewal in ESC and leukemic stem cell (LSC).
Methodology/Principal Findings: To understand the mechanism(s) of SALL4 function(s), we sought to identify SALL4-
associated proteins by tandem mass spectrometry. Components of a transcription repressor Mi-2/Nucleosome Remodeling
and Deacetylase (NuRD) complex were found in the SALL4-immunocomplexes with histone deacetylase (HDAC) activity in
ESCs with endogenous SALL4 expression and 293T cells overexpressing SALL4. The SALL4-mediated transcriptional
regulation was tested on two potential target genes: PTEN and SALL1. Both genes were confirmed as SALL4 downstream
targets by chromatin-immunoprecipitation, and their expression levels, when tested by quantitative reverse transcription
polymerase chain reaction (qRT-PCR), were decreased in 293T cells overexpressing SALL4. Moreover, SALL4 binding sites at
the promoter regions of PTEN and SALL1 were co-occupied by NuRD components, suggesting that SALL4 represses the
transcriptions of PTEN and SALL1 through its interactions with the Mi-2/NuRD complex. The in vivo repressive effect(s) of
SALL4 were evaluated in SALL4 transgenic mice, where decreased expressions of PTEN and SALL1 were associated with
myeloid leukemia and cystic kidneys, respectively.
Conclusions/Significance: In summary, we are the first to demonstrate that stem cell protein SALL4 represses its target
genes, PTEN and SALL1, through the epigenetic repressor Mi-2/NuRD complex. Our novel finding provides insight into the
mechanism(s) of SALL4 functions in kidney development and leukemogenesis.
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Introduction
The human SAL gene family, SALL1, SALL2, SALL3 and
SALL4, was originally cloned on the basis of DNA sequence
homology to the Drosophila homeotic gene spalt [1–3]. In
Drosophila, SAL is a zinc finger transcription factor and required
for development of the posterior head and anterior tail segment in
early embryos, as well as for later stages of organogenesis and adult
wing morphogenesis [4,5]. SAL-related genes have been isolated
fromCaenorhabditiselegans[6,7],fish[8,9],Xenopus[10,11],mice
[12], and humans [1,13]. Each of these homologues is expressed
during embryonic development, as well as in specific adult tissues.
Human SALL4 mutations are associated with the Duane-radial
ray syndrome (DRRS, OMIM#126800, also known as Okihiro
syndrome), which is a human autosomal-dominant syndrome
involving multiple organ defects, including kidney malformation
[1,13–15]. SALL4 is also essential for maintenance of pluripotent
and self-renewal properties of embryonic stem cells (ESCs) by
interacting with other two key regulators in ESCs, NANOG and
OCT4 [16–19]. Loss of SALL4 expression in mouse ESCs results
in downregulation of OCT4 and spontaneous differentiation.
Significant zygotic SALL4 transcription in mice occurs after the 4-
cell stage and continues to increase until the blastocyst stage. By
10.5 days postcoitum, SALL4 is detectable mainly in the stem/
progenitor populations in various organ systems including the
brain and bone marrow of the embryo and later in the adult. This
may suggest that SALL4 is not only involved in ESCs but also in
adult stem cells [19]. Moreover, we have reported that SALL4 is
constitutively expressed in human leukemia cell lines and primary
acute myeloid leukemia (AML) cells. We have generated a SALL4
transgenic mouse model in which SALL4B, one of the SALL4
isoforms, is overexpressed. These mice exhibit a pre-leukemic
dysplastic phase and subsequently develop AML transformation
that is transplantable [20,21]. In addition, 50% of these transgenic
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indicate that SALL4 is a critical gene for ESC properties, kidney
development, and leukemogenesis, and is involved in the biological
functions of various types of stem cells. Defining the precise
mechanism(s) and downstream target genes of SALL4 is of great
importance to the field of stem cell study.
Recent studies have demonstrated that a conserved N-terminal 12
amino acid domain of SALL1 and FRIEND OF GATA1 (FOG-1) is
sufficient for recruiting Mi-2/Nucleosome Remodeling and Deace-
tylase (NuRD) complex and mediating transcriptional repression
[22–24]. It is known that acetylation status of histones is associated
with the regulation of gene transcription. Generally, when histones
are acetylated, chromatin becomes loosely packed euchromatin and
gene expression is activated. In contrast, deacetylated histones lead to
condensed heterochromatin and repressed gene expression [25]. In
mammalian cells, there are two major histone deacetylation
complexes, Mi-2/NuRD and Sin3. These two protein complexes
share four common components, HDAC1, HDAC2, RbAp46 and
RbAp48. Mi-2/NuRD complex additionally includes Mi-2, MTA-1,
MTA-2, p66 and MBD3. Among these eight factors, HDAC1 and
HDAC2 are histone deacetylases, RbAp46 and RbAp48 are histone
binding proteins, and Mi-2 is a chromatin remodeling ATPase.
Therefore, histone deacetylation and chromation remodeling
ATPase activities are uniquely linked in this single protein complex
Mi-2/NuRD, whose function is to produce compactly packed,
hypoacetylated nucleosomes that switch an active, hyperacetylate
promoter to its inactivated state [26].
In this study, we report that SALL4, a protein containing the
same conserved 12 amino acid motif [22,24,27], associates with the
NuRD complex and functions as a strong transcription repressor.
Moreover, we tested the effect of SALL4-NuRD complex in two
SALL4 target genes: Phosphatase and Tensin Homolog (PTEN)
and SALL1. These two genes are chosen for our studies based on
their roles(s) in ESC, leukemogenesis and kidney development,
which are closely relevant to the biological functions of SALL4.
PTEN is a tumor suppressor gene and essential for both normal
hematopoiesis and leukemogenesis [28–30]. It has been shown
that deletion of PTEN results in generation of leukemic stem cells
as well as depletion of normal hematopoietic stem cells [28,31–32].
Absence of PTEN can also alter ESC properties and impair kidney
development [33–35]. SALL1 is a stem cell factor in kidney
development [36], and is mutated in patients with Townes-Brocks
syndrome (TBS), whose features include renal malformations [37–
39]. Genetic targeting of mouse SALL1 results in severe renal
dysplasia or complete agenesis, indicating that SALL1 plays an
essential role in early kidney development. In addition, SALL1 is
expressed in both human and mouse ESCs, and has been
associated with a potential role in leukemogenesis [40].
In this study, we have demonstrated that SALL4 represses the
expression of PTEN and SALL1 by interacting with the NuRD
complex. This inhibition may at least contribute in part to the
SALL4-induced leukemia and kidney abnormalities in the
transgenic mice.
Materials and Methods
Mice
Generation of transgenic SALL4B mice has been previously
described [20].
Immunocytochemistry
293T cells were transiently transfected with SALL4A or
SALL4B constructs. After 48 h, the transfected cells were fixed
with 4% paraformaldehye-PBS for 20 min at room temperature,
then permeabilized in 0.5% Trixon X-100 in PBS, and then
blocked with 3% BSA in PBS for 1 h at room temperature.
Blocked cells were incubated with anti-SALL4 antibody for
overnight at 4uC followed by incubation with secondary antibody
(Alexa Flour 488 conjugated anti-rabbit IgG, Molecular Probes,
Invitrogen, Carlsbad, California) diluted at 1:1000 in PBS for
30 min at room temperature.
Reporter Assays
Full length SALL4B was cloned in frame to the GAL4 DNA
binding domain. As reporter constructs, pGAL4-tk-Luc was used,
which contains the luciferase gene under the control of the
thymidine kinase (tk) promoter with upstream GAL4 binding sites.
The 293T cells were transiently transfected with the GAL4-
SALL4B fusion plasmid, luciferase reporter plasmid (GAL4-tk-
Luc), and cytomegalovirus-b-galactosidase control plasmid. After
48 h, the transfected cells were extracted with lysis buffer and used
for luminescence measurements with luminometer. These exper-
iments were performed in triplicate.
Cell culture
All cell cultures were maintained at 37uC with 5% CO2. 293T
cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM, Invitrogen) supplemented with 10% fetal bovine serum
(FBS, Invitrogen) and 50 U/ml penicillin/streptomycin (Invitro-
gen). D3 mouse ES cells (CRL-1934, ATCC) were cultured on
0.1% gelatin-coated plates in DMEM supplemented with 15%
FBS, 2 mM L-Glutamine, 16 nucleoside mixture, 0.1 mM b-
Figure 1. Nuclear localization of SALL4. (A) Immunofluorescence
of 293T cells transfected with either SALL4A (upper panel) or SALL4B
(lower panel). Cells were stained with polyclonal anti SALL4 antibody
(right) and DAPI (left). Both SALL4A and SALL4B were observed only in
the nuclei of transfected. (B) Cellular fractionation with Western
blotting showing SALL4A and SALL4B in the nuclei. Lysates from
SALL4A or SALL4B-expressed 293Tcells were fractionated. 50 ug of
subcellular fractions were separated on the SDS-PAGE and probed with
the anti-SALL4 antibody.
doi:10.1371/journal.pone.0005577.g001
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ml: ESGRO, Chemicon International).
Purification of SALL4 protein complex (Mass
Spectrometry)
293T cells expressing FLAG-tagged SALL4B or an empty vector
were grown to confluence on culture dishes in DMEM containing
10% FBS. Cells were lysed with buffer A (50 mM Tris-HCl, pH 7.5,
100 mM NaCl, 2 mM MgCl2, 10% glycerol, 1% Nonidet P-40,
2 mM Na3VO4, 10 mM NaF, and protein inhibitor cocktail
(Sigma). A total cell extract was prepared after centrifugation
(14,0006g for 20 min) and then immunoprecipitated with anti-
FLAG M2 agarose (Sigma) for 5 hr at 4uC. After washing with buffer
A 10 times, bound proteins were eluted twice with 0.25 mg/ml
FLAG peptide (Sigma), resolved on 4–15% or 7% SDS-PAGE (Bio-
Rad),subjected to silver staining, and analyzed by mass spectrometry.
HDAC activity assay
HDAC assays were performed using the HDAC fluorimetric
assay kit (Upstate) according to the manufacturer’s instructions.
Briefly, lysates from 293T cells expressing SALL4 or from ES cells
were immunoprecipitated with anti-FLAG antibody (for 293T–
SALL4B transfectants), anti-SALL4 antibody (for 293T-SALL4A
transfectants and ES cells) or rabbit IgG (as a control). The
immunocomplexes were washed with lysis buffer 5 times and then
incubated with fluorescene-producing substrate (Fluor de lys
substrate) with or without Trichostatin A (TSA, 200 nM) for
40 min at room temperature with rocking. These assays were
stopped by adding Fluore de Lys developer (50 ul). Fluorescent,
deacetylated substrate was detected in a 96-well plate using
Victor3V 1420 Multilabel Counter (Perkin Elmer).
Co-Immunoprecipitation
293T cells were transfected with pcDNA3-SALL4A or SALL4B
and harvested after 48 hours. Nuclear proteins of SALL4A or
SALL4B-expressed 293T cells and D3 cells were prepared with
Nuclear Extract kit (Active Motif) according to manufacturer’s
instructions. 1 mg of nuclear protein was incubated with 5 mgo f
anti-SALL4 antibody or rabbit IgG (Upstate) at 4uC overnight.
20 ml protein G beads (Sigma) were added into protein-antibody
mixture and incubated for 3 hours at 4uC. Then the beads were
washed 5 times with 1 ml of wash buffer containing 0.1% NP-40.
Interacting proteins were eluted with 50 ml1 6 protein sample
loading buffer. The eluted sample was loaded onto 4%–15% SDS-
PAGE gels (Bio-Rad) and the following Western blots were
performed with antibodies against HDAC1 (H6287, Sigma),
HDAC2 (H2663, Sigma), MTA-2 (sc-9402, Santa Cruz), Mi-2
(sc-11378, Santa Cruz) and Sin3A (sc-5299, Santa Cruz).
ChIP (Chromatin immunoprecipitation)
293T cells were transiently transfected either with a full length
SALL4A or SALL4B or with an empty vector. Cells were cross-
linked, lysed, and sonicated. Chromatin immunoprecipitations
were conducted with a polyclonal anti-SALL4, anti-HDAC2
(H2663, Sigma), or anti-acetylated histone H3 (Ac-H3, Upstate)
antibody. With quantitative real-time PCR, PTEN and SALL1
primers specific to a 150-bp ,250-bp region of the promoters
were used to validate pulldown DNA fragments. Fold enrichment
Figure 2. Transcriptional repression by tethered SALL4B. (A) Schematic representation of the GAL4 fusion protein (GAL4–SALL4B) and
luciferase reporters (GAL4-tk-Luc). 56Gal4, five copies of the GAL4-binding site; tk, thymidine kinase core promoter. (B) Constructs expressing SALL4B
fused to the C-terminus of GAL4 (1–93) were transfected into 293T cells, along with the reporter GAL-tk-Luc. Luciferase activities were normalized to
the internal ß-galactosidase control. Different molar ratios of GAL4-SALL4B and GAL4-tk-Luc were used for transfection.
doi:10.1371/journal.pone.0005577.g002
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of all three types of transfected cells.
Quantitative real-time PCR (qPCR)
Pulldown DNA from ChIP was measured by UV spectropho-
tometry. About 60 ng of DNA was utilized to perform qRCR with
iTaq SYBR Green Supermix (Bio-Rad). Reactions were carried
out in duplicates.
Quantitative real-time RT-PCR (qRT-PCR)
Total RNA was extracted with Trizol reagent (Invitrogen)
according to manufacturer’s instructions, and the concentration
was measured by UV spectrophotometry. 100 ng of total RNA
was applied to conduct qRT-PCR by using iScript One-Step RT-
PCR Kit with SYBR Green (Bio-Rad). The average threshold
cycle for each gene was determined from duplicate reactions and
the expression level was normalized to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH).
Mouse Magnetic resonance imaging (MRI) imaging
This group of experiments was done by the core facility of Small
Animal MRI Laboratory at Brigham and Women Hospital
according to a previously published procedure [41]. Briefly, mouse
MRI measurements were performed using a 4.7 T Bruker Avance
horizontal bore system equipped with a 200 mm inner diameter
gradient set capable of 30 G/cm gradient strength or a 7T Bruker
Pharmascan system. The mice were anesthetized with 1%
isoflurane in an oxygen/air mixture. The animals’ respiratory and
cardiac rates were monitored using Biotrig Software (4.7T) or SA
Instruments monitoring device (Stony Brook, NY for 7T system).
The animals were imaged on the 4.7T system with RARE sequence
(TR=2000 ms, TE effect=25 ms) in the coronal and axial planes
with a 1 mm slice thickness and with the number of slices sufficient
to cover entirety of the kidneys. A matrix size of 1286128 and field
of view (FOV) of 2.562.5 cm
2 were used for the images.
Mouse Tissues and Hematoxylin and Eosin Staining
Methods on mouse tissue collection and hematoxylin and eosin
(H&E)staining were previously described [20].
Results
SALL4 functions as a transcriptional repressor
The presence of multiple characteristic zinc finger domains in
SALL4 suggests that SALL4 could be a transcription factor. To
verify this, we first examined the subcellular localization of two
variants of SALL4 proteins (SALL4A and SALL4B) by immuno-
fluorescentstainingandcellularfractionation with Westernblotting.
As shown in Figure 1A, when SALL4A and SALL4B were
overexpressed in 293T cells, both proteins were localized only to
the nuclei of the cells. The resulting cytoplasmic and nuclear
fractions were analyzed by Western blotting and SALL4A and
SALL4B were again detected exclusively in the nuclei (Figure 1B).
Secondly, we fused the SALL4B isoform to the minimum DNA-
binding domain of the yeast transcription factor GAL4 (1–93) and
used the tk-GALpx3-Luc reporter construct to examine the effect
of the SALL4B isoform on the activity of the reporter containing
the GAL4 binding site. GAL4–SALL4B remarkably repressed
transcription in a dose-dependent manner (Figure 2), which,
combined with the nuclear localizations of SALL4 proteins,
supports the notion that SALL4 functions as a strong transcrip-
tional repressor. We chose the SALL4B isoform for this functional
assay because we generated a transgenic SALL4B mouse model
that can be used for in vivo functional study correlation.
SALL4 associates with Mi-2/nucleosome remodeling and
deacetylase (NuRD) complex in vitro
In order to understand the mechanism(s) whereby SALL4
represses gene transcription, and to identify cofactors of SALL4,
we transfected FLAG-tagged SALL4B vector into 293T cells and
purified the SALL4B-containing protein complex. Several bands
were observed in only FLAG-SALL4B bound proteins but not in
mock controls (Figure 3). Followed by tandem mass spectrometry
analysis, in the 200-kDa band 42 peptides were identified as Mi-2b
which has been shown to be the specific component of Mi-2/
NuRD complex. In addition, the other bands were identified as
MTA1 (7 peptides), MTA2 (18 peptides), p66 (16 peptides),
HDAC1 (1 peptide), and RbAP46 (1 peptide). All those proteins
are the components of the Mi-2/NuRD complex that plays a key
role in transcriptional repression through its association with
sequence specific DNA-binding protein.
Mass spectrometry results were confirmed by Western blotting
analyses (Figure 4A). We observed that HDAC2 (Figure 4A) and
RbAP48 (data not shown), the other two components of Mi-2/
NuRD complex, were also present as SALL4B-bound proteins. In
contrast, Sin3A, a unique protein in the Sin3 histone deacetylase
complex, was not detected in SALL4B-containing proteins. This
excludes the possibility that SALL4 might be in the Sin3 complex.
To determine whether SALL4A binds to the Mi-2/NuRD
complex as well, and whether endogenous SALL4 in general binds
to this complex, we did coimmunoprecipitation and Western
blotting experiments using the extracts from SALL4A-expressing
Figure3.SALL4B-boundproteinsincludethecomponentsofMi-
2/NuRD complex. Extracts from 293Tcells expressing FLAG-SALL4B or
mock vector only were immunoprecipitated with anti-FLAG M2 agarose.
SALL4B-bound proteins were fractionated by SDS-PAGE, detected by
silver staining and identified by tandem mass spectrometry.
doi:10.1371/journal.pone.0005577.g003
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endogenous SALL4 expression. It showed that both exogenous
SALL4A and endogenous SALL4 were bound to HDAC1,
HDAC2, MTA2 and Mi-2 (Figure 4B and 4C). Taken altogether,
these results have demonstrated that SALL4 associates with Mi-2/
NuRD complex and indicates that SALL4-repressed gene
transcription could be mediated by nucleosome remodeling and
histone deacetylation.
SALL4-bound protein complex has histone deacetylase
(HDAC) activity
To test whether SALL4-containing protein complex has the
capacity to deacetylate histones, we measured its HDAC activity.
As shown in Figure 4D, both exogenous SALL4A and SALL4B-
containing protein complexes exhibited 2 to 5 fold higher HDAC
activity than the IgG control pull-down samples. Similarly, a 2-fold
increase in HDAC activity was observed in endogenous SALL4-
associated protein complex in ES cells in comparison to the
control. Moreover, when both exogenous and endogenous
SALL4-interacting protein complexes were incubated with
trichostatin A (TSA), a histone deacetylase specific inhibitor, the
HDAC activity was dramatically reduced. It suggests that a
SALL4-bound protein complex including NuRD components
exhibits histone deacetylase activity.
SALL4 binds to the promoter regions of PTEN and SALL1
and represses their expression in vitro
To determine the molecular mechanism(s) of SALL4 in normal
hematopoiesis, leukemogenesis and ESC development, we have
mapped SALL4 global gene targets using chromatin-immunopre-
Figure 4. SALL4 associates with Mi-2/NuRD complex and SALL4-interacting protein complex exhibits histone deacetylase (HDAC)
activity. Extracts from SALL4B-expressed 293T cells (A), SALL4B-expressed 293T cells (B), or mouse ES cells, (C) were immunoprecipated with an
anti-SALL4 antibody or rabbit IgG control followed by Western blotting with indicated antibodies. The HDAC activity of SALL4-bound protein
complex was measured using the fluorimetric assay with or without the TSA (D). Data represent at least two independent experiments. Error bars
denote standard deviation (SD).
doi:10.1371/journal.pone.0005577.g004
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PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5577Figure 5. SALL4 co-occupies the same promoter regions of PTEN as HDAC2 and represses its expression in vitro. (A) Diagram of PTEN
promoter. Antibody against SALL4 was used to immunoprecipitate DNA fragments from SALL4A and SALL4B-expressed 293T cells and fold
enrichment was compared to input after normalization with GAPDH. Four pairs of primers in the PTEN promoter region (22629 bp to 21419 bp)
were used in ChIP-qPCR analysis with the ATG site defined as 0. Region I (22629 bp to 22383 bp) was found to be bound by SALL4B and region III
(21706 bp to 21571 bp) was found to be bound by both SALL4A and SALL4B (B). The same ChIP-qPCR assay was done with an anti-HDAC2
antibody (C) or an anti-acetyl H3 antibody (D). Results are representative of at least two independent experiments. Error bars indicate standard
deviations. NA: no amplicon in qPCR. (E) The expression level of PTEN was reduced 30% in SALL4-expressed 293T cells (SALL4A and SALL4B)
compared to empty vector controls (EV). The mRNA level was normalized with internal control GAPDH. Data represent as mean6SD, n$3, P,0.05.
doi:10.1371/journal.pone.0005577.g005
SALL4 and NuRD
PLoS ONE | www.plosone.org 6 May 2009 | Volume 4 | Issue 5 | e5577Figure 6. SALL4 co-occupies the same promoter regions of SALL1 as HDAC2 and inhibits its transcription in vitro. (A) Diagram of
SALL1 promoter. Antibody against SALL4 was used to immunoprecipitate DNA fragments from SALL4A and SALL4B-expressed 293T cells and fold
enrichment was compared to input after normalization with GAPDH. Five pairs of primers spanning SALL1 promoter region (22246 bp to 21279 bp)
were used in ChIP-qPCR analysis. Region II (22057 bp to 21867 bp) was found to be bound by SALL4A and region V (21464 bp to 21279 bp) was
found to be bound by SALL4B (B). The same ChIP-qPCR assay was done with an anti-HDAC2 antibody (C) or an anti-acetyl H3 antibody (D). Results
are representative of at least two independent experiments. Error bars indicate standard deviations. NA: no amplicon in qPCR. ND: not done. (E) The
mRNA level of SALL1 was reduced 35% and 45% in SALL4A and SALL4B-expressed 293T cells (SALL4A and SALL4B) compared to empty vector
controls (EV). The expression level was normalized with internal control GAPDH. Data represent as mean6SD, n$3, P,0.05.
doi:10.1371/journal.pone.0005577.g006
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normal human CD34
+ bone marrow cells, myeloid leukemic NB4
cells and human ESCs. Two genes that have been implicated in
ESC, kidney development and leukemogenesis, PTEN and
SALL1, were identified as potential SALL4 downstream target
genes. We then sought to validate whether SALL4 binds to the
promoter regions of these two genes using regular ChIP coupled
with qPCR. Chromatin from 293T cells expressing either
SALL4A or SALL4B was prepared, sonicated and immunopre-
cipitated with a rabbit polyclonal antibody against SALL4. QPCR
was carried out with a series of primers specific for PTEN and
SALL1 promoters, which were designed based on ChIP-on-chip
results and covered possible SALL4 binding sites and adjacent
non-binding sequences (Figure 5A & 6A). We observed a 2–3 fold
enrichment in SALL4 pull-down at its binding site in the PTEN
and SALL1 promoters when compared to input (no antibody
added), while there was no enrichment at the non-binding sites
(Figure 5B and 6B). We also observed that SALL4 was able to bind
the promoter regions of these two genes in either mouse ESCs, two
human AML samples including M0 (FAB classification) or AML
transformed from CML (chronic myeloid leukemia) using ChIP-
on-ChIP assays (data not shown).
Interestingly, SALL4A and SALL4B exhibited different binding
sites at the promoter regions of PTEN and SALL1. This could be
due to the differences between the two isoforms in DNA binding
zinc finger domains. While both SALL4A and SALL4B share the
same N- and C-terminal domains, SALL4A has eight zinc finger
domains, and SALL4B has only three. This structural variation
may result in different binding affinity of SALL4A and SALL4B to
the DNA and may explain why their binding sites at the promoters
of PTEN and SALL1 are not identical.
Moreover, with the aim of determining the regulation of PTEN
and SALL1 by SALL4, we examined the expression level of PTEN
and SALL1 in 293T cells overexpressing SALL4 using qRT-PCR.
We observed that compared to cells transfected with the empty
vector, the expression level of PTEN and SALL1 in SALL4A-
expressed cells was decreased by 30% and 35%, respectively.
Similarly, when SALL4B was overexpressed, the mRNA level of
PTEN or SALL1 was reduced by 30% and 50% respectively
(Figure 5E & 6E). Altogether, these results demonstrated that both
PTEN and SALL1 are direct down-stream target genes of SALL4
and their expressions are negatively regulated by SALL4.
SALL4 and Mi-2/NuRD complex co-occupy the same
genomic binding sites at the promoter regions of PTEN
and SALL1
As shown above, SALL4 associates with the Mi-2/NuRD
complex that is known to be involved in transcriptional repression.
Thus, we propose that SALL4 represses the expression of PTEN
and SALL1 via the NuRD complex. To test this hypothesis, we
performed ChIP-qPCR analysis using the anti-HDAC2 antibody
and examined whether HDAC2 and SALL4 shared the same
binding site(s) at the promoters of PTEN and SALL1. We have
shown that SALL4 binds to the specific promoter regions of PTEN
(22629 bp,22383 bp, Region I, and 21706 bp,21571 bp,
Region III) and SALL1 (22057 bp,21867 bp, Region II, and
21464 bp,21279 bp, Region V). In this experiment, in HDAC2
pulldown fragments of both SALL4A and SALL4B transfected
cells, 2 to 5 fold enrichment was detected at the SALL4 binding
sites of PTEN and SALL1 promoters when compared with input.
However, there was no enrichment observed in the non-binding
sites of both genes (Figure 5C & 6C). The same result was obtained
from the ChIP-qPCR assay using anti-MTA2 antibody (data not
shown). Therefore, these results illustrate that SALL4 and NuRD
complex co-occupy the same promoter sites of PTEN and SALL1
and indicate that SALL4 downregulates the transcription of those
two genes through histone deacetylation. In addition, we
performed the same analysis using anti-acetyl Histone H3
antibody. This analysis showed when SALL4 was overexpressed
the enrichment at SALL4-binding sites of PTEN and SALL1 was
decreased from 35% to 83% respectively (Figure 5D & 6D), which
suggested that there was reduced acetylation of histones H3 at
these binding regions. These results strengthen the notion that
SALL4-NuRD protein complex suppresses the expressions of
PTEN and SALL1, the two SALL4 direct downstream target
genes, by deacetylating the histones at their promoter regions.
SALL4 inhibits expression of PTEN and SALL1 in vivo
We have generated a SALL4B transgenic mice mouse model.
We observed that 50% of examined SALL4B transgenic mice had
cystic kidneys (Table 1 and Figure 7A–C), which suggested that
SALL4 could be involved in kidney development. Since SALL1 is
considered as one of the key factors in kidney development, we
checked the expression of SALL1 in the kidneys of these transgenic
mice. Consistent with in vitro studies, the transcription of SALL1 in
transgenic mouse kidneys was decreased to 45% of those in wild
type controls (Figure 7F).
SALL4B transgenic mice also displayed MDS-like symptoms and
subsequent AML transformation
20 (Figure 7 D&E). Since PTEN, a
target of SALL4, plays an essential role in hematopoietic stem cell
self-renewal and leukemogenesis, we further explored whether
regulation of PTEN expression by SALL4 was involved in SALL4
induced AML in vivo. The mRNA level of PTEN in the bone
marrow (BM) samples obtained from SALL4B transgenic mice was
examined by qRT-PCR. It was observed that the expression level of
PTEN was decreased 20% in BM cells of SALL4B transgenic mice
compared to litter mate controls (Figure 7F).
Table 1. Phenotypical characterization of SALL4B transgenic
mice.
ID number Founder Gender Age (month) Phenotype
448 448 f 19 AML
464 464 m 19 MDS
4 464 m 22 Cystic kidney/MDS
88 504 m 2 Cystic kidney/MDS
89 504 m 4 Cystic kidney/MDS
90 504 m 8 AML
86 504 f 18 AML
87 504 f 8 AML
2234 504 m 3 Cystic kidney/MDS
1879 504 m 4 MDS
2837 504 m 4 Cystic kidney/MDS
504 504 m 19 Cystic kidney and MDS
1959 506 m 1 Cystic Kidney
506 506 m 19 Cystic kidney and MDS
25 507 m 8 Cystic Kidney/AML
26 507 m 14 Cystic kidney/MDS
27 507 m 22 MDS/AML
507 507 f 24 AML
doi:10.1371/journal.pone.0005577.t001
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PLoS ONE | www.plosone.org 8 May 2009 | Volume 4 | Issue 5 | e5577Figure 7. SALL4 represses the transcriptions of PTEN and SALL1 in vivo. Cystic kidneys were observed in 50% of the SALL4B transgenic mice.
(A) MRI imaging on mouse kidneys. Compared to the control normal kidney, the cystic kidney had a 1.35 mm cyst that is indicated by an arrow. The
gross picture of a cystic kidney was shown in (B) with the arrow indicating the cystic area. (C) Histological morphologies on normal kidney (C–I,
magnification: 640) and cystic kidneys (C-ii and C-iii indicated by the arrow, 640) were presented after stained with Hematoxylin and Eosin (H&E
stain). (D) Normal bone marrow from control mice (H&E stain with magnification:6100). (E) Leukemic bone marrow from transgenic mice (H&E stain
with magnification:6100). (F) The transcriptions of PTEN or SALL1 were decreased 20% and 45% respectively in SALL4B transgenic mice BM or kidney
samples. Data represent as mean6SD, n=4, P,0.05.
doi:10.1371/journal.pone.0005577.g007
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PLoS ONE | www.plosone.org 9 May 2009 | Volume 4 | Issue 5 | e5577These findings indicated that the association of SALL4 and Mi-
2/NuRD complex could be related to multiple biological
processes, and the inhibition of PTEN and SALL1 expression by
SALL4 may at least partially contribute to SALL4 induced AML
and cystic kidneys in the transgenic mice.
Discussion
Zinc-finger transcription factor SALL4 is essential for human
embryonic development. It plays an essential role in the
maintenance of pluripotency and self-renewal properties of
embryonic stem cells (ESC) by activation of another pluripotency
factor, Oct4. In addition, we have shown that constitutive
expression of SALL4 contributes to leukemogenesis in adult mice
by activating Bmi-1 [42], a key regulator in hematopoietic stem
cells (HSCs) and leukemic stem cells (LSCs) [43]. Parallel loss-of-
function studies have also demonstrated that SALL4 is essential for
the survival of leukemic cells, and the apoptotic phenotype that is
caused by down-regulation of SALL4 can be rescued by
overexpression of Bmi-1 [44]. It appears that SALL4 is a unique
gene that is involved in self-renewal in ESC, HSC and LSC, in
part by activation of stem cell factors. To our best knowledge,
SALL4 may be one of the few genes that create such a connection.
Thus, further studies on the mechanism(s) of SALL4 function will
add value and advance the field of stem cell research.
We have mapped SALL4 global gene targets using chromatin-
immunoprecipitation followed by microarray hybridization (ChIP-
on-chip) in three types of cells that are related to SALL4 biological
functions: leukemic cells [42], ESCs, and primary normal CD34+
cells (unpublished data), which have been correlated with the
expression of these gene targets. During these studies we have
noticed that SALL4 activates as well as represses its target genes.
In addition, SALL1, another SALL gene family member, is
capable of repressing transcriptional activity. These findings
prompted us to ask whether SALL4 had transcriptional repression
activity.
In this study, we have shown that SALL4 can act as a repressor
in some context. More importantly, we have made a novel
observation that SALL4 directly connects the epigenetic modula-
tors (NuRD repressor complex) to its downstream target genes,
such as PTEN and SALL1 (Figure 8). The NuRD complex has
both histone deacetylase and ATP-dependent nucleosome remod-
eling activity. It plays roles in transcriptional repression through its
association with sequence specific DNA-binding protein in ESC,
development, hematopoietic differentiation and tumorigenesis
[25,26,45–47]. We have shown through tandem mass spectrom-
etry and/or coimmunoprecipitation that both the endogenous and
the exogenous SALL4 can bind to the NuRD complex. In
addition, the SALL4-bound protein complex has histone deace-
tylase (HDAC) activity. To make our study relevant to the
biological functions of SALL4, we have searched genes that are
involved in ESC, leukemogenesis, and kidney development, and
have chosen PTEN and SALL1 as exemplar target genes to
demonstrate the mechanism of SALL4-mediated gene repression.
Both SALL4 isoforms, SALL4A and SALL4B, can interact with
this complex to regulate their down stream targets (PTEN and
SALL1), although they do so through different binding sites on the
promoter regions of these genes. The SALL4-mediated repression
Figure 8. Proposed functional model for SALL4/NuRD complex. SALL4 recruits the NuRD complex to the specific promoter regions on its
target genes (i.e. PTEN and SALL1). This results in histone deacetylation at these regions, which leads to condensed heterochromatin and repressed
gene expressions.
doi:10.1371/journal.pone.0005577.g008
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PLoS ONE | www.plosone.org 10 May 2009 | Volume 4 | Issue 5 | e5577of the expression of PTEN and SALL1 has been confirmed both in
vitro and in vivo and is associated with phenotypes observed in
SALL4B transgenic mice, i.e. AML and cystic kidneys, respec-
tively. While both genes are involved in ESCs, kidney develop-
ment and leukemogenesis, SALL1 is best studied for its essential
role in kidney development, and PTEN is known as a key
regulator in leukemic stem cells. Therefore, we tested the
expression levels of these two genes in their most functionally
relevant tissues: SALL1 in kidneys and PTEN in the bone marrow.
Both genes were down-regulated in the SALL4B transgenic mice
in comparison to their wild type littermates. In addition, our
previous study on downregulation of SALL4 in leukemic NB4 cells
Figure 9. Working hypothesis:SALL4 recruits epigenetic modulators to specific DNA sequences on the promoter regions of its
downstream targets. A, SALL4 represses its downstream targets by recruiting NuRD to specific promoter regions that results in histone
deacetylation and transcription repression. B, SALL4 activates its downstream targets by recruiting a histone methyltransferase complex to specific
promoter regions that results in H3-K4 trimethylation and transcription activation. C, Alternatively, SALL4 recruits both complexes to specific regions
on the promoters of target genes. It can either repress or activate the transcription of these genes by balancing the interactions with both complexes.
doi:10.1371/journal.pone.0005577.g009
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PLoS ONE | www.plosone.org 11 May 2009 | Volume 4 | Issue 5 | e5577has demonstrated that PTEN is upregulaetd when the expression
of SALL4 is knocking down [42].
Our early study on SALL4-mediated activation of Bmi-1
suggests that SALL4 may be involved in epigenetic modification(s),
such as trimethylation of histone 3 lysine 4 (H3K4), which is
associated with gene activation [48]. Additional study in our lab
has indicated that the SALL4-bound protein complex has histone
H3K4 trimethylation activity (unpublished data). In this study, we
have discovered that SALL4 can interact with an epigenetic
repressor complex, NuRD, in gene silencing (Figure 8). Taken
together, we have made the novel observation that SALL4
connects the epigenetic modulators (both the activator and
repressor complex) to its downstream target genes, a phenomenon
that has not been reported for other stem cell proteins, such as
Oct4, Nanog, and Sox2. Though further studies are needed to
define the precise mechanism(s) that determine SALL4 to work as
an activator versus a repressor, this observation should provide us
with a unique opportunity to study the connection between the
genetic and epigenetic programs in stem cells in the future.
Furthermore, we propose the following working model: it is
possible that SALL4 recruits epigenetic modulators to specific
DNA sequences in the promoter regions of its downstream targets
for either activation or repression (Figure 9).
The genetic program in ESC consists of a core transcriptional
network including SALL4, OCT4, SOX2, and NANOG. The
epigenetic state of an ESC is very unique and is described as
‘‘bivalent’’, wherein markers for repression (trimethylation of
histone 3 lysine 27, H3-K27) and activation (trimethylation of
histone 3 lysine 4, H3-K4) on certain developmental genes coexist.
This unique epigenetic state is essential for ESC pluripotency
[49,50]. It remains unknown how the core transcriptional network
is linked to this unique ‘stem cell’’ epigenetic state in maintaining
properties of ESCs. Our studies suggest that SALL4 may be the
key element that connects the epigenetic and genetic programs in
ESCs. It is possible that SALL4 recognizes specific DNA binding
sites for epigenetic modulators and activates or represses a SALL4
dependent transcriptional network to regulate the self-renewal and
pluripotency in ESCs.
Being a pluripotency gene, SALL4 is present at a very early
stage along with Oct4 during development, earlier than Nanog.
Unlike Oct4 and Nanog, it is present in adult tissue stem cells (such
as hematopoietic stem cells) and cancer stem cells (such as
leukemic stem cells). The unique role of SALL4 in the self-renewal
properties shared by ESCs, HSCs, and LSCs could be associated
with its ability to recruit epigenetic modulators to regulate various
downstream targets in various stem cells. Our study on SALL4 as
a repressor and its association with the NuRD complex is only the
first step in understanding the SALL4-mediated epigenetic
modification in ESC, adult stem cells and cancer stem cells.
Future studies on SALL4 in various stem cell models should help
us to address the fundamental connection between chromatin
structure and cell function.
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